Scholars Central

Short communicationPublished 14 Sep 2020

COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the Severity of the Disease

Authors: Naoki Yamamoto

Genome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa, Japan

Diagnostic Pathology: Open Access

Volume 5 · Issue 3 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Throughout history, humans have been threatened by various infectious diseases. As of August 22, 2020, a new coronavirus infection, COVID-19, has been raging around the world, infecting approximately 23 million people and killing approximately 800,000. Although COVID-19 is a serious infectious disease, it is at most comparable to the 1968 Hong Kong flu given the far more deaths caused by previous devastations, such as the plague, smallpox, Spanish flu, AIDS, tuberculosis and malaria. However, we are still in the midst of the epidemic, and it is difficult to project the extent of damage COVID-19 will ultimately inflict.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiagnostic Pathology: Open Access
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Naoki Yamamoto”